Literature DB >> 24945893

Academic medical product development: an emerging alliance of technology transfer organizations and the CTSA.

Lynn M Rose1, Maaike Everts, Caren Heller, Christine Burke, Nathaniel Hafer, Scott Steele.   

Abstract

To bring the benefits of science more quickly to patient care, the NIH National Center Advancing Translational Sciences (NCATS) supports programs that enhance the development, testing, and implementation of new medical products and procedures. The NCATS clinical and translational science award (CTSA) program is central to that mission; creating an academic home for clinical and translational science and supporting those involved in the discovery and development of new health-related inventions. The technology transfer Offices (TTO) of CTSA-funded universities can be important partners in the development process; facilitating the transfer of medical research to the commercial sector for further development and ultimately, distribution to patients. The Aggregating Intellectual Property (IP) Working Group (AWG) of the CTSA public private partnerships key function committee (PPP-KFC) developed a survey to explore how CTSA-funded institutions currently interface with their respective TTOs to support medical product development. The results suggest a range of relationships across institutions; approximately half have formal collaborative programs, but only a few have well-connected programs. Models of collaborations are described and provided as examples of successful CTSA/TTO partnerships that have increased the value of health-related inventions as measured by follow-on funding and industry involvement; either as a consulting partner or licensee.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  CTSA; product; technology transfer

Mesh:

Year:  2014        PMID: 24945893      PMCID: PMC4268266          DOI: 10.1111/cts.12175

Source DB:  PubMed          Journal:  Clin Transl Sci        ISSN: 1752-8054            Impact factor:   4.689


  3 in total

1.  US academic drug discovery.

Authors:  Stephen Frye; Marina Crosby; Teresa Edwards; Rudolph Juliano
Journal:  Nat Rev Drug Discov       Date:  2011-06       Impact factor: 84.694

2.  A venture capital view of challenges, opportunities, and innovation in biomedical research.

Authors:  L T Ratcliffe
Journal:  Clin Pharmacol Ther       Date:  2011-02       Impact factor: 6.875

3.  Drug discovery in an academic setting: playing to the strengths.

Authors:  Donna M Huryn
Journal:  ACS Med Chem Lett       Date:  2013-01-17       Impact factor: 4.345

  3 in total
  2 in total

1.  The REDCap consortium: Building an international community of software platform partners.

Authors:  Paul A Harris; Robert Taylor; Brenda L Minor; Veida Elliott; Michelle Fernandez; Lindsay O'Neal; Laura McLeod; Giovanni Delacqua; Francesco Delacqua; Jacqueline Kirby; Stephany N Duda
Journal:  J Biomed Inform       Date:  2019-05-09       Impact factor: 6.317

2.  Collaborative academic medical product development: An 8-year review of commercialization outcomes at the Institute of Translational Health Sciences.

Authors:  Lynn M Rose; Fiona Wills; Connie Bourassa-Shaw; Terri L Butler; Jeanette Griscavage Ennis; Kim Emmons; Patrick Shelby; Meher Antia; Kim Folger Bruce
Journal:  J Clin Transl Sci       Date:  2017-08-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.